(v) Combined, priming with sHLA-G1 and EV derived from HLA-G1 positive or negative transfected SUM149 BC cells seem to affect CD8+ T cells complementary by targeting either the ILT-2 positive or ILT-2 negative subpopulation, respectively. The gene discussed is LILRB1; the disease is breast cancer.